Thromboelastography to Monitor Clotting/Bleeding Complications in Patients Treated with the Molecular Adsorbent Recirculating System
Figure 2
MARS therapy efficiently clears serum creatinin and bilirubin. Evolution of the parameters serum creatinin and bilirubin during MARS therapy. Each line represents a pair of values from an individual MARS treatment session. Gray dots represent values from uneventful MARS session, black open circles sessions complicated by device clotting and black triangles sessions with bleeding complications. Closed black circles connected by a thick black line indicate mean values. Significant values are indicated, sessions analysed (), of which () were uneventful, () were complicated by bleeding and () by clotting of the MARS filter system.
